Literature DB >> 28351052

Diabetic Macular Edema.

Francesco Bandello, Maurizio Battaglia Parodi, Paolo Lanzetta, Anat Loewenstein, Pascale Massin, Francesca Menchini, Daniele Veritti.   

Abstract

Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the center of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. In the last few years, many diagnostic tools have proven to be useful in the detection and the monitoring of the features characterizing DME. On the other hand, several therapeutic approaches can now be proposed on the basis of the DME-specific characteristics. The aim of the present chapter is to thoroughly delineate the clinical and morphofunctional characteristics of DME and its current treatment perspectives. The pathogenesis and the course of DME require a complex approach with multidisciplinary intervention both at the systemic and local levels.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2017        PMID: 28351052     DOI: 10.1159/000455277

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  28 in total

1.  Hyperglycemia Enhances Constriction of Retinal Venules via Activation of the Reverse-Mode Sodium-Calcium Exchanger.

Authors:  Yen-Lin Chen; Wenjuan Xu; Robert H Rosa; Lih Kuo; Travis W Hein
Journal:  Diabetes       Date:  2019-05-14       Impact factor: 9.461

2.  Three-dimensional spheroids of choroid-retinal vascular endothelial cells as an in-vitro model for diabetic retinopathy: Proof-of-concept investigation.

Authors:  Manish Gore; Ankit Tiwari; Devashree Jahagirdar; Angayarkanni Narayanasamy; Ratnesh Jain; Prajakta Dandekar
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-05-21

3.  Different Anti-Vascular Endothelial Growth Factor for Patients With Diabetic Macular Edema: A Network Meta-Analysis.

Authors:  Xian Wang; Xiaoning He; Fang Qi; Jia Liu; Jing Wu
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

4.  Subthreshold yellow laser for fovea-involving diabetic macular edema in a series of patients with good vision: effectiveness and safety of a fovea-sparing technique.

Authors:  Alejandro Filloy; Victor Chong; Eduard Solé
Journal:  BMC Ophthalmol       Date:  2020-07-06       Impact factor: 2.209

5.  Can the dexamethasone intravitreal implant Ozurdex be safely administered in an out-of-operating room setting?

Authors:  María Del Pino Cidad-Betegón; Félix Armadá-Maresca; Gloria Amorena-Santesteban; Javier Coca-Robinot; Oriana D'Anna-Mardero; Irene de la Rosa-Pérez; Beatriz Manzano-Muñoz; Jesús García-Martínez; Mónica Asencio-Durán; Gema Casado-Abad
Journal:  J Drug Assess       Date:  2020-03-31

6.  Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy.

Authors:  Jian Guan; Na Cai; Li-Min Liu; Ning Zhao; Ning-Ning Liu
Journal:  Diabetes Ther       Date:  2020-04-30       Impact factor: 2.945

Review 7.  Real-World Efficacy and Safety of Fluocinolone Acetonide Implant for Diabetic Macular Edema: A Systematic Review.

Authors:  Laurent Kodjikian; Stephanie Baillif; Catherine Creuzot-Garcher; Marie-Noëlle Delyfer; Frédéric Matonti; Michel Weber; Thibaud Mathis
Journal:  Pharmaceutics       Date:  2021-01-07       Impact factor: 6.321

8.  Expression of microRNA-155-5p in patients with refractory diabetic macular edema and its regulatory mechanism.

Authors:  Junwen He; Rui Zhang; Shan Wang; Lu Xie; Chengfeng Yu; Tao Xu; Yanzi Li; Tao Yan
Journal:  Exp Ther Med       Date:  2021-07-08       Impact factor: 2.447

9.  Constriction of Retinal Venules to Endothelin-1: Obligatory Roles of ETA Receptors, Extracellular Calcium Entry, and Rho Kinase.

Authors:  Yen-Lin Chen; Yi Ren; Wenjuan Xu; Robert H Rosa; Lih Kuo; Travis W Hein
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-10-01       Impact factor: 4.799

10.  Hyperglycemia Augments Endothelin-1-Induced Constriction of Human Retinal Venules.

Authors:  Yen-Lin Chen; Robert H Rosa; Lih Kuo; Travis W Hein
Journal:  Transl Vis Sci Technol       Date:  2020-08-03       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.